These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers. Galan-Herrera JF, Poo JL, Rosales-Sanchez O, Fuentes-Fuentes E, Cariño L, Burke-Fraga V, Namur S, Parra MG. Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138 [Abstract] [Full Text] [Related]
3. Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats. Albarellos GA, Ambros LA, Landoni MF. J Vet Pharmacol Ther; 2005 Aug; 28(4):363-9. PubMed ID: 16050816 [Abstract] [Full Text] [Related]
4. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose. Wagenlehner FM, Kinzig-Schippers M, Tischmeyer U, Wagenlehner C, Sörgel F, Dalhoff A, Naber KG. Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856 [Abstract] [Full Text] [Related]
5. Linezolid pharmacokinetics in pediatric patients: an overview. Jungbluth GL, Welshman IR, Hopkins NK. Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S153-7. PubMed ID: 14520140 [Abstract] [Full Text] [Related]
6. Pharmacokinetics of levofloxacin after single and multiple oral doses in patients undergoing intermittent haemodialysis. Tsaganos T, Kouki P, Digenis P, Giamarellou H, Giamarellos-Bourboulis EJ, Kanellakopoulou K. Int J Antimicrob Agents; 2008 Jul; 32(1):46-9. PubMed ID: 18534825 [Abstract] [Full Text] [Related]
7. Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections. Abdel-Rahman SM, Benziger DP, Jacobs RF, Jafri HS, Hong EF, Kearns GL. Pediatr Infect Dis J; 2008 Apr; 27(4):330-4. PubMed ID: 18316988 [Abstract] [Full Text] [Related]
8. Characterization of the pharmacokinetic disposition of levofloxacin in stallions after intravenous and intramuscular administration. Goudah A, Abo El-Sooud K, Shim JH, Shin HC, Abd El-Aty AM. J Vet Pharmacol Ther; 2008 Oct; 31(5):399-405. PubMed ID: 19000258 [Abstract] [Full Text] [Related]
9. Safety and pharmacokinetics of multiple 750-milligram doses of intravenous levofloxacin in healthy volunteers. Chow AT, Fowler C, Williams RR, Morgan N, Kaminski S, Natarajan J. Antimicrob Agents Chemother; 2001 Jul; 45(7):2122-5. PubMed ID: 11408234 [Abstract] [Full Text] [Related]
10. Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies. Timmers GJ, Dijstelbloem Y, Simoons-Smit AM, van Winkelhoff AJ, Touw DJ, Vandenbroucke-Grauls CM, Huijgens PC. Bone Marrow Transplant; 2004 Apr; 33(8):847-53. PubMed ID: 14755314 [Abstract] [Full Text] [Related]
11. Pharmacokinetics of levofloxacin in healthy Thai male volunteers. Chulavatnatol S, Chindavijak B, Vibhagool A, Wananukul W, Sriapha C, Sirisangtragul C. J Med Assoc Thai; 1999 Nov; 82(11):1127-35. PubMed ID: 10659548 [Abstract] [Full Text] [Related]
12. The clinical pharmacokinetics of levofloxacin. Fish DN, Chow AT. Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926 [Abstract] [Full Text] [Related]